• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

PLoS One . Relationship between sociodemographic, clinical, and laboratory characteristics and severity of COVID-19 in pediatric patients

tetano

Editor, Senior Moderator
PLoS One


. 2024 May 7;19(5):e0283037.
doi: 10.1371/journal.pone.0283037. eCollection 2024. Relationship between sociodemographic, clinical, and laboratory characteristics and severity of COVID-19 in pediatric patients

Cristian Roca[SUP] 1 [/SUP], Adriana Asturizaga[SUP] 2 [/SUP], Nelson Villca[SUP] 3 [/SUP], Ramiro Cabrera[SUP] 4 [/SUP], Raul Copana-Olmos[SUP] 5 6 [/SUP], Vladimir Aguilera-Avendano[SUP] 7 [/SUP], Claudia Estrada-Villarroel[SUP] 7 [/SUP], Mariel Andrea Forest-Yepez[SUP] 8 [/SUP], Marcia Torrez-Santos[SUP] 9 [/SUP], Adela Felipa Magne-Calle[SUP] 9 [/SUP], Maria Ofelia Foronda-Rios[SUP] 10 [/SUP], Liz Malena Pena-Helguero[SUP] 10 [/SUP], Monica Montalvo[SUP] 4 [/SUP], Delina Torrez[SUP] 11 [/SUP], Mirna Toco[SUP] 12 [/SUP], Miguel Cespedes[SUP] 13 [/SUP], Ingrid Davalos[SUP] 14 [/SUP], Natalie M Bowman[SUP] 15 [/SUP]; COVID19 Research Group in Bolivia



Affiliations
Abstract

COVID-19 affects children less seriously than adults; however, severe cases and deaths are documented. This study objective is to determine socio-demographic, clinical and laboratory indicators associated with severe pediatric COVID-19 and mortality at hospital entrance. A multicenter, retrospective, cross-sectional study was performed in 13 tertiary hospitals in Bolivia. Clinical records were collected retrospectively from patients less than 18 years of age and positive for SARS-CoV-2 infection. All variables were measured at hospital entrance; outcomes of interest were ICU admission and death. A score for disease severity was developed using a logistic regression model. 209 patients were included in the analysis. By the end of the study, 43 (20.6%) of children were admitted to the Intensive care unit (ICU), and 17 (8.1%) died. Five indicators were independently predictive of COVID-19 severity: age below 10 years OR: 3.3 (CI95%: 1.1-10.4), days with symptoms to medical care OR: 2.8 (CI95%: 1.2-6.5), breathing difficulty OR: 3.4 (CI95%: 1.4-8.2), vomiting OR: 3.3 (CI95%: 1.4-7.4), cutaneous lesions OR: 5.6 (CI95%: 1.9-16.6). Presence of three or more of these risk factors at hospital entrance predicted severe disease in COVID-19 positive children. Age, presence of underlying illness, male sex, breathing difficulty, and dehydration were predictive of death in COVID-19 children. Our study identifies several predictors of severe pediatric COVID-19 and death. Incorporating these predictors, we developed a tool that clinicians can use to identify children at high risk of severe COVID-19 in limited-resource settings.


 
Back
Top Bottom